Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy

BACKGROUND: Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfeminine individuals who have not had orchidectomy; however, there is no evidence to guide optimal treatment choice. OBJECTIVE: We aimed to compare add-on cyproterone acetat...

Descripción completa

Detalles Bibliográficos
Autores principales: Angus, Lachlan, Leemaqz, Shalem, Ooi, Olivia, Cundill, Pauline, Silberstein, Nicholas, Locke, Peter, Zajac, Jeffrey D, Cheung, Ada S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612061/
https://www.ncbi.nlm.nih.gov/pubmed/31234145
http://dx.doi.org/10.1530/EC-19-0272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612061/
https://www.ncbi.nlm.nih.gov/pubmed/31234145
http://dx.doi.org/10.1530/EC-19-0272

Ejemplares similares